Platelet indices and angiogenesis markers in hypertensive disorders of pregnancy

Abstract

AbstractIntroductionActivated platelets exert a key role in the pathogenesis of preeclampsia (PE). There is evidence of distinctive patterns of platelet indices in PE in comparison to healthy pregnancies, therefore these indices can be potential tools for PE detection, risk stratification, and management. Considering the vascular aspects of its pathophysiology, PE is characterized by the increased levels of soluble FMS‐like tyrosine kinase‐1 (sFlt‐1) an antiangiogenic factor, and reduced placental growth factor (PlGF), a proangiogenic factor. This study aimed to assess the platelet indices in hypertensive disorders of pregnancy (HDP) and its correlation with angiogenesis‐related biomarkers.MethodsThe groups for the study were: control (n = 114); gestational hypertension; (n = 112), and PE (n = 42). The platelet indices included were platelet counts (PLT‐I and PLT‐F), mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (PCT), platelet large cell ratio (P‐LCR), and immature platelet fraction (IPF# and IPF%). Serum levels of sFlt‐1 and PlGF were assessed.ResultsPLT‐I, PLT‐F, and PCT% were lower in PE, while MPV, PDW, P‐LCR, IPF%, and IPF# were increased. The parameter MPV presented the best performance for the discrimination of PE. There was a moderate positive correlation between sFlt‐1 levels and MPV, PDW, and P‐LCR.ConclusionPlatelet indices can be potentially applied as additional tools for the diagnosis and management of HDP. Activated platelets may act as an extra source of sFlt‐1 in PE.